Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test
- 30 September 2010
- journal article
- Published by Elsevier BV in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 76 (1), 105-111
- https://doi.org/10.1016/j.ejpb.2010.05.006
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage formEuropean Journal of Pharmaceutical Sciences, 2009
- Dissolution Media Simulating Conditions in the Proximal Human Gastrointestinal Tract: An UpdatePharmaceutical Research, 2008
- Current perspectives in dissolution testing of conventional and novel dosage formsInternational Journal of Pharmaceutics, 2007
- Development of dissolution tests for oral extended-release productsPharmaceutical Science & Technology Today, 1998
- Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage FormsPharmaceutical Research, 1998
- Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II DrugsPharmaceutical Research, 1998
- Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tractAdvanced Drug Delivery Reviews, 1997
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995
- Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and WomenPharmaceutical Research, 1993
- Correlation of the Gastric Emptying of Nondisintegrating Tablets with Gastrointestinal MotilityPharmaceutical Research, 1991